BOI:EPA
Boiron SA
19,10 €
0,00%
(0,00) 1D
19 қар., 17:35:06 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
19,05 €
High
19,15 €
Low
19,05 €
Mkt. cap
335,12 млн
Avg. vol.
4,45 мың
Volume
258,00
P/E ratio
12,66
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 млн
No. of employees
3 мың
Open
19,05 €
High
19,15 €
Low
19,05 €
Mkt. cap
335,12 млн
Avg. vol.
4,45 мың
Volume
258,00
P/E ratio
12,66
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 млн
No. of employees
3 мың
News stories
From web sources and news partners
Benzinga
·
19 минут бұрын
Anthropic Jumps 27% in Record Debut, S&P 500 Eyes Sixth Straight Loss: Stock Market Today
The Motley Fool
·
7 сағат бұрын
Is Investing in an S&P 500 ETF Really Enough? Here's My Honest Take.
Barron's
·
5 сағат бұрын
S&P 500 Futures Rise in Premarket Trading; Credicorp, Intercorp Finl Svcs Lead
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA
CEO-
Employees2,62 мың
Founded1932 ж. 07 мау.
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteboiron.fr